Pharmaceuticals, Biotechnology and Life Sciences
SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage…
Utah Governor Spencer Cox opens 190,000-square-foot buildingNusano platform capable of producing more than 40 different radioisotopes for healthcare and industryNew…
MISSISSAUGA, Ontario, Aug. 21, 2025 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for…
MISSISSAUGA, Ontario, Aug. 21, 2025 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce…
ZUG, Switzerland, Aug. 21, 2025 (GLOBE NEWSWIRE) — Focused execution in Q2 2025 to advance Oculis’ pipeline in ophthalmology and…
Focused execution in Q2 2025 to advance Oculis’ pipeline in ophthalmology and neuro-ophthalmologyOCS-01: Both pivotal Ph3 DIAMOND trials are fully…
Product sales from Olverembatinib in the first half of 2025 increased 93% year-over-year to US$30.3 million (RMB217.4 million), primarily attributable to…
MELBOURNE, Australia and INDIANAPOLIS, Aug. 21, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces…
First-in-human, Phase 1 Study of LRK-4189 to Begin in the Fourth QuarterCAMBRIDGE, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) — Larkspur…
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 20, 2025 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13)…